TrialEuropean urology2023

Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.

Wassim Abida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.